Indivior PLC (INDV)

Ardsley Advisory Partners LP grew its holdings in shares of Indivior PLC (NASDAQ: INDV) by 16.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Comm...

New York City-based Newtyn Management increased its stake in Indivior by nearly 1.6 million shares in the third quarter, resulting in a net position change of $62.8 million. The transaction represents...

Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in Indivior PLC (NASDAQ: INDV) in the undefined quarter, according to its most recent disclosure with the Securities an...

RICHMOND, Va. , Nov. 20, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced the Company has concluded the legacy U.S. Department of Justice (DOJ) matter by paying in full the outstanding...

RICHMOND, Va. , Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37th Annual Healthcare Conference: Piper Sandler 37th Annual Hea...

INDV, PRLB, LVS and OII top Zacks' efficiency screen with strong margins and solid earnings surprises....

Medicaid and commercially insured patients with high adherence to SUBLOCADE® experienced lower relapse rates and reduced healthcare resource utilization Adherence to SUBLOCADE was associated with lowe...

Indivior PLC ( INDV ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Jason Thompson - Vice President of Investor Relations Joseph Ciaffoni - CEO & Director Patrick Barry - Chi...

Indivior is already profitable and cash-generative, and is set to grow significantly in 2026. Its key medication's delivery system offers opioid use disorder patients more reliable outcomes....

Indivior PLC (INDV) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.54 per share a year ago....